HomeANIP • NASDAQ
add
ANI Pharmaceuticals Inc Common Stock
Previous close
$59.53
Day range
$58.99 - $60.60
Year range
$52.50 - $77.00
Market cap
1.30B USD
Avg Volume
464.86K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 197.12M | 43.43% |
Operating expense | 109.08M | 48.98% |
Net income | 15.68M | -13.87% |
Net profit margin | 7.95 | -40.00% |
Earnings per share | 1.70 | 40.50% |
EBITDA | 37.89M | 27.41% |
Effective tax rate | 21.54% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 155.19M | -34.86% |
Total assets | 1.29B | 41.32% |
Total liabilities | 848.96M | 93.95% |
Total equity | 443.47M | — |
Shares outstanding | 20.02M | — |
Price to book | 2.85 | — |
Return on assets | 2.91% | — |
Return on capital | 3.52% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 15.68M | -13.87% |
Cash from operations | 34.99M | 91.53% |
Cash from investing | -19.85M | -322.17% |
Cash from financing | -9.91M | 49.78% |
Net change in cash | 4.94M | -33.90% |
Free cash flow | 19.79M | 131.14% |
About
Founded
2001
Headquarters
Website
Employees
897
